User profiles for Joel N. Blankson

JOEL N BLANKSON

Verified email at jhmi.edu
Cited by 13901

[HTML][HTML] Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure

…, SB Laskey, DIS Rosenbloom, J Lai, JN Blankson… - Cell, 2013 - cell.com
Antiretroviral therapy fails to cure HIV-1 infection because latent proviruses persist in resting
CD4 + T cells. T cell activation reverses latency, but <1% of proviruses are induced to …

The challenge of viral reservoirs in HIV-1 infection

JN Blankson, D Persaud… - Annual review of …, 2002 - annualreviews.org
▪ Abstract A viral reservoir is a cell type or anatomical site in association with which a
replication-competent form of the virus accumulates and persists with more stable kinetic properties …

[PDF][PDF] Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation

…, HC Yang, H Zhang, JB Margolick, JN Blankson… - Immunity, 2012 - cell.com
Highly active antiretroviral therapy (HAART) suppresses HIV-1 replication but cannot eliminate
the virus because HIV-1 establishes latent infection. Interruption of HAART leads to a …

A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

…, N Wada, YC Ho, H Zhang, JB Margolick, JN Blankson… - Nature, 2019 - nature.com
A stable latent reservoir for HIV-1 in resting CD4 + T cells is the principal barrier to a cure 1 ,
2 – 3 . Curative strategies that target the reservoir are being tested 4 , 5 and require accurate…

[HTML][HTML] SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

…, CC Garliss, JN Blankson - The Journal of clinical …, 2021 - Am Soc Clin Investig
Recent studies have shown T cell cross-recognition of SARS-CoV-2 and common cold
coronavirus spike proteins. However, the effect of SARS-CoV-2 vaccines on T cell responses to …

[HTML][HTML] Monocyte-derived macrophages contain persistent latent HIV reservoirs

…, L Pohlenz, EN Shirk, LH Rubin, JN Blankson… - Nature …, 2023 - nature.com
The development of persistent cellular reservoirs of latent human immunodeficiency virus (HIV)
is a critical obstacle to viral eradication since viral rebound takes place once anti-…

Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors

JN Blankson, JR Bailey, S Thayil, HC Yang… - Journal of …, 2007 - Am Soc Microbiol
Elite suppressors (ES) are untreated human immunodeficiency virus type 1 (HIV-1)-infected
individuals who control viremia to levels below the limit of detection of current assays. The …

Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations

…, TM Williams, RF Siliciano, JN Blankson - The Journal of …, 2006 - rupress.org
Rare human immunodeficiency virus 1–infected individuals, termed elite suppressors (ES),
maintain plasma virus levels of <50 copies/ml and normal CD4 counts without therapy. The …

[HTML][HTML] Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay

…, SA Rabi, J Lai, S Chioma, JN Blankson… - PLoS …, 2013 - journals.plos.org
HIV-1 persists in infected individuals in a stable pool of resting CD4 + T cells as a latent but
replication-competent provirus. This latent reservoir is the major barrier to the eradication of …

The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with human immunodeficiency virus (HIV)

…, O Laeyendecker, AL Cox, JN Blankson - Clinical Infectious …, 2022 - academic.oup.com
Joel N Blankson Joel N Blankson … Bezawit A Woldemeskel, Andrew H Karaba, Caroline
C Garliss, Evan J Beck, Kristy H Wang, Oliver Laeyendecker, Andrea L Cox, Joel N Blankson, …